Skip to content

Hydroxyurea-Loaded Nanostructured Lipid Carriers for Enhanced In Vitro Cytotoxicity and Drug Delivery.

Sep 2026 · Journal of Visualized Experiments · Vol 235 · 0 citations
Medicine

TL;DR

The NLC formulations studied, particularly NX-ST, effectively enhanced HU's therapeutic performance by improving stability, delivery efficiency, and anticancer activity.

Abstract

Hydroxyurea (HU) is an established anticancer drug used to treat chronic myelogenous leukemia, but its therapeutic efficacy is limited by rapid clearance, variable bioavailability, and dose-related toxicity. This study aimed to improve HU delivery by developing hydroxyurea-loaded nanostructured lipid carriers (NLCs) using different surfactant combinations. Three formulations, including NX-ST (Tween 80-SDS), NX-CT (Cremophor EL-Tween 80), and NX-CS (Cremophor EL-SDS), were prepared and evaluated for particle size, polydispersity index (PDI), zeta potential, encapsulation efficiency (EE), and cytotoxic activity. The formulations exhibited nanoscale particle sizes (67.377 to 110 nm), acceptable PDI (<0.35), high zeta potential (-30.033 to -46.433 mV), and good encapsulation efficiency (78.189 to 86.626%), indicating stable formulations. The release profile exhibited an approximately linear increase over the 0.5-6 h period, followed by a plateau. Cytotoxicity studies showed enhanced anticancer activity compared with free HU (IC₅₀ = 722.57 µg/mL). The formulation NX-ST demonstrated the highest cytotoxicity (IC₅₀ = 225 ± 21.47 µg/mL), consistent with enhanced drug delivery; the contribution of improved cellular uptake is inferred and was not directly measured in this study. The NLC formulations studied, particularly NX-ST, effectively enhanced HU's therapeutic performance by improving stability, delivery efficiency, and anticancer activity.

View source

Similar papers

Sep 2026

Targeted Colorectal Cancer Therapy Using Cabozantinib-Loaded PLGA Nanoparticles: Formulation, Cytotoxicity, and Molecular Docking Analysis.

Improved Cabozantinib delivery via Cabozantinib-loaded poly(lactic-co-glycolic acid) nanoparticles, prepared by solvent evaporation represents improved Cabozantinib delivery via Cabozantinib-loaded poly(lactic-co-glycolic acid) nanoparticles that overcomes pharmacokinetic pitfalls of CBZT.

Aryan Thakkar, Sankha Bhattacharya, R. Shinde · 0 citations
Aug 2026

Formulation and In vitro Characterization of Rosuvastatin Calcium Loaded Chitosan Nanoparticles for Sustained Drug Release

It is suggested that RST-loaded chitosan nanoparticles represent a promising oral nanocarrier system with sustained release characteristics and the potential to improve the oral performance of poorly water-soluble drugs such as rosuvastatin calcium.

M. Sarwer, R. M. Sarfraz, Asif Mahmood et al. · 0 citations
Aug 2026

Doxorubicin-Postbiotic Transethosomes: Formulation and In Vitro Evaluation

The developed transethosomal system showed favorable physicochemical properties, sustained drug release, stability, antioxidant and antimicrobial activity, and significant cytotoxicity against melanoma cells, which support its potential as a multifunctional topical platform for localized melanoma therapy and provide a...

Kirandeep Kaur, Preeti Patel, Balak Das Kurmi · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.